Global Natural Killer Cell Therapies Market Research Report 2020

1 Natural Killer Cell Therapies Market Overview

• 1.1 Product Overview and Scope of Natural Killer Cell Therapies
• 1.2 Natural Killer Cell Therapies Segment by Type
  • 1.2.1 Global Natural Killer Cell Therapies Sales Growth Rate Comparison by Type (2020-2026)
  • 1.2.2 NK Cell Therapies
  • 1.2.3 NK Cell Directed Antibodies
• 1.3 Natural Killer Cell Therapies Segment by Application
  • 1.3.1 Natural Killer Cell Therapies Sales Comparison by Application: (2020-2026)
  • 1.3.2 Cancer
  • 1.3.3 Gastrointestinal Diseases
  • 1.3.4 Others
• 1.4 Global Natural Killer Cell Therapies Market Size Estimates and Forecasts
  • 1.4.1 Global Natural Killer Cell Therapies Revenue 2015-2026
  • 1.4.2 Global Natural Killer Cell Therapies Sales 2015-2026
  • 1.4.3 Natural Killer Cell Therapies Market Size by Region: 2020 Versus 2026

2 Global Natural Killer Cell Therapies Market Competition by Manufacturers

• 2.1 Global Natural Killer Cell Therapies Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Natural Killer Cell Therapies Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Natural Killer Cell Therapies Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Natural Killer Cell Therapies Manufacturing Sites, Area Served, Product Type
• 2.5 Natural Killer Cell Therapies Market Competitive Situation and Trends
  • 2.5.1 Natural Killer Cell Therapies Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Natural Killer Cell Therapies Players (Opinion Leaders)

3 Natural Killer Cell Therapies Retrospective Market Scenario by Region

• 3.1 Global Natural Killer Cell Therapies Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Natural Killer Cell Therapies Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Natural Killer Cell Therapies Market Facts & Figures by Country
  • 3.3.1 North America Natural Killer Cell Therapies Sales by Country
  • 3.3.2 North America Natural Killer Cell Therapies Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Natural Killer Cell Therapies Market Facts & Figures by Country
  • 3.4.1 Europe Natural Killer Cell Therapies Sales by Country
  • 3.4.2 Europe Natural Killer Cell Therapies Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Natural Killer Cell Therapies Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Natural Killer Cell Therapies Sales by Region
  • 3.5.2 Asia Pacific Natural Killer Cell Therapies Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Natural Killer Cell Therapies Market Facts & Figures by Country
  • 3.6.1 Latin America Natural Killer Cell Therapies Sales by Country
  • 3.6.2 Latin America Natural Killer Cell Therapies Sales by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Natural Killer Cell Therapies Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Natural Killer Cell Therapies Sales by Country
  • 3.7.2 Middle East and Africa Natural Killer Cell Therapies Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Natural Killer Cell Therapies Historic Market Analysis by Type

• 4.1 Global Natural Killer Cell Therapies Sales Market Share by Type (2015-2020)
• 4.2 Global Natural Killer Cell Therapies Revenue Market Share by Type (2015-2020)
• 4.3 Global Natural Killer Cell Therapies Price Market Share by Type (2015-2020)
• 4.4 Global Natural Killer Cell Therapies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Natural Killer Cell Therapies Historic Market Analysis by Application

• 5.1 Global Natural Killer Cell Therapies Sales Market Share by Application (2015-2020)
• 5.2 Global Natural Killer Cell Therapies Revenue Market Share by Application (2015-2020)
• 5.3 Global Natural Killer Cell Therapies Price by Application (2015-2020)

6 Company Profiles and Key Figures in Natural Killer Cell Therapies Business

• 6.1 Nektar Therapeutics
  • 6.1.1 Corporation Information
  • 6.1.2 Nektar Therapeutics Description, Business Overview
  • 6.1.3 Nektar Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Nektar Therapeutics Products Offered
  • 6.1.5 Nektar Therapeutics Recent Development
• 6.2 Innate
  • 6.2.1 Innate Corporation Information
  • 6.2.2 Innate Description, Business Overview
  • 6.2.3 Innate Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Innate Products Offered
  • 6.2.5 Innate Recent Development
• 6.3 Affimed
  • 6.3.1 Affimed Corporation Information
  • 6.3.2 Affimed Description, Business Overview
  • 6.3.3 Affimed Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Affimed Products Offered
  • 6.3.5 Affimed Recent Development
• 6.4 Chipscreen Biosciences
  • 6.4.1 Chipscreen Biosciences Corporation Information
  • 6.4.2 Chipscreen Biosciences Description, Business Overview
  • 6.4.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Chipscreen Biosciences Products Offered
  • 6.4.5 Chipscreen Biosciences Recent Development
• 6.5 Fate Therapeutics
  • 6.5.1 Fate Therapeutics Corporation Information
  • 6.5.2 Fate Therapeutics Description, Business Overview
  • 6.5.3 Fate Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Fate Therapeutics Products Offered
  • 6.5.5 Fate Therapeutics Recent Development
• 6.6 Glycostem
  • 6.6.1 Glycostem Corporation Information
  • 6.6.2 Glycostem Description, Business Overview
  • 6.6.3 Glycostem Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Glycostem Products Offered
  • 6.6.5 Glycostem Recent Development
• 6.7 Dragonfly Therapeutics
  • 6.6.1 Dragonfly Therapeutics Corporation Information
  • 6.6.2 Dragonfly Therapeutics Description, Business Overview
  • 6.6.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Dragonfly Therapeutics Products Offered
  • 6.7.5 Dragonfly Therapeutics Recent Development
• 6.8 Kiadis Pharma
  • 6.8.1 Kiadis Pharma Corporation Information
  • 6.8.2 Kiadis Pharma Description, Business Overview
  • 6.8.3 Kiadis Pharma Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Kiadis Pharma Products Offered
  • 6.8.5 Kiadis Pharma Recent Development
• 6.9 NantWorks
  • 6.9.1 NantWorks Corporation Information
  • 6.9.2 NantWorks Description, Business Overview
  • 6.9.3 NantWorks Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 NantWorks Products Offered
  • 6.9.5 NantWorks Recent Development
• 6.10 Nkarta Therapeutics
  • 6.10.1 Nkarta Therapeutics Corporation Information
  • 6.10.2 Nkarta Therapeutics Description, Business Overview
  • 6.10.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Nkarta Therapeutics Products Offered
  • 6.10.5 Nkarta Therapeutics Recent Development
• 6.11 Fortress Biotech
  • 6.11.1 Fortress Biotech Corporation Information
  • 6.11.2 Fortress Biotech Natural Killer Cell Therapies Description, Business Overview
  • 6.11.3 Fortress Biotech Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Fortress Biotech Products Offered
  • 6.11.5 Fortress Biotech Recent Development

7 Natural Killer Cell Therapies Manufacturing Cost Analysis

• 7.1 Natural Killer Cell Therapies Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Natural Killer Cell Therapies
• 7.4 Natural Killer Cell Therapies Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Natural Killer Cell Therapies Distributors List
• 8.3 Natural Killer Cell Therapies Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Natural Killer Cell Therapies Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Natural Killer Cell Therapies by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Natural Killer Cell Therapies by Type (2021-2026)
• 10.2 Natural Killer Cell Therapies Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Natural Killer Cell Therapies by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Natural Killer Cell Therapies by Application (2021-2026)
• 10.3 Natural Killer Cell Therapies Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Natural Killer Cell Therapies by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Natural Killer Cell Therapies by Region (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List